Pages

Friday, May 23, 2014

NeuralStem Inc. Depression Trial Data To Be Presented At The Annual Meeting

NSI-189 is Neuralstem's first-in-class, lead neurogenic small molecule compound.

http://ift.tt/TCgQ9u

No comments:

Post a Comment